Ac-TPSLPTPPTR-NH2

Ref. 3D-PP49077

Información del producto

• Nombre: Ac-TPSLPTPPTR-NH2

Descripción

Peptide Ac-TPSLPTPPTR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-TPSLPTPPTR-NH2 include the following: Protein production is an early biomarker for RNA-targeted therapies WK Self , KM Schoch, J Alex - Annals of Clinical , 2018 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/acn3.657 Quantification of tau in cerebrospinal fluid by immunoaffinity enrichment and tandem mass spectrometry T McAvoy, ME Lassman, DS Spellman, Z Ke - Clinical , 2014 - academic.oup.comhttps://academic.oup.com/clinchem/article-abstract/60/4/683/5621721 Porphyromonas gingivalis in Alzheimer's disease brains: Evidence for disease causation and treatment with small-molecule inhibitors SS Dominy, C Lynch, F Ermini, M Benedyk - Science , 2019 - science.orghttps://www.science.org/doi/abs/10.1126/sciadv.aau3333 Magnetic materials for the selective analysis of peptide and protein biomarkers S Piovesana , A Laura Capriotti - Current Medicinal Chemistry, 2017 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cmc/2017/00000024/00000005/art00003 IP-LC-MSMS Enables Identification of Three Tau O-GlcNAcylation Sites as O-GlcNAcase Inhibition Pharmacodynamic Readout in Transgenic Mice Overexpressing S Bijttebier, D Rodrigues Martins - Journal of Proteome , 2023 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.2c00822 Development of immunoprecipitation-two-dimensional liquid chromatography-mass spectrometry methodology as biomarker read-out to quantify S Bijttebier, C Theunis, F Jahouh, DR Martins - of Chromatography A, 2021 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0021967321004234 Antibody-free quantification of seven tau peptides in human CSF using targeted mass spectrometry P Bros, J Vialaret , N Barthelemy , V Delatour - Frontiers in , 2015 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fnins.2015.00302/full Cerebrospinal fluid phospho-tau T217 outperforms T181 as a biomarker for the differential diagnosis of Alzheimer's disease and PET amyloid-positive patient NR Barthelemy , RJ Bateman , C Hirtz , P Marin - Alzheimer's research & , 2020 - Springerhttps://link.springer.com/article/10.1186/s13195-020-00596-4 Quantitative proteomics with isotope dilution analysis: principles and applications K Kabytaev , A Stoyanov - Current Proteomics, 2016 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cp/2016/00000013/00000001/art00009 Mass-spectrometry-based method to quantify in parallel tau and amyloid beta 1-42 in CSF for the diagnosis of Alzheimer's disease G Pottiez, L Yang, T Stewart, N Song - Journal of proteome , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.6b00829 Tau kinetics in neurons and the human central nervous system C Sato , NR Barthelemy , KG Mawuenyega - Neuron, 2018 - cell.comhttps://www.cell.com/neuron/pdf/S0896-6273(18)30136-3.pdf Evaluation of SP3 for antibody-free quantification of tau in CSF mimic and brain by mass spectrometry C Jacquemin, N Villain , R Azevedo - Journal of Mass , 2024 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/14690667231218912 Mind/Body Blog BS Stetka - Circulation, 2019 - psychiatryneurology.nethttps://psychiatryneurology.net/blog/page/14/

• Marca: Biosynth